In recent decades, non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease in the Western world, and the occurrence of its complications, such as hepatocellular carcinoma (HCC), has rapidly increased. Obesity and diabetes are considered not only the main triggers for the development of the disease, but also two independent risk factors for HCC. Single nucleotide polymorphisms (such as PNPLA3, TM6SF2 and MBOAT7) are related to the susceptibility to the development of HCC and its progression. Therefore, an appropriate follow-up of these patients is needed for the early diagnosis and treatment of HCC. To date, international guidelines recommend the use of ultrasonography with or without alpha-fetoprotein (AFP) in patients with advanced fibrosis. Furthermore, the use of non-invasive tools could represent a strategy to implement surveillance performance. In this review, we analyzed the main risk factors of NAFLD-related HCC, the validated screening methods and the future perspectives.

Pennisi G., Celsa C., Giammanco A., Spatola F., Petta S. (2019). The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(22), 5613 [10.3390/ijms20225613].

The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives

Pennisi G.;Celsa C.;Giammanco A.;Spatola F.;Petta S.
2019-01-01

Abstract

In recent decades, non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease in the Western world, and the occurrence of its complications, such as hepatocellular carcinoma (HCC), has rapidly increased. Obesity and diabetes are considered not only the main triggers for the development of the disease, but also two independent risk factors for HCC. Single nucleotide polymorphisms (such as PNPLA3, TM6SF2 and MBOAT7) are related to the susceptibility to the development of HCC and its progression. Therefore, an appropriate follow-up of these patients is needed for the early diagnosis and treatment of HCC. To date, international guidelines recommend the use of ultrasonography with or without alpha-fetoprotein (AFP) in patients with advanced fibrosis. Furthermore, the use of non-invasive tools could represent a strategy to implement surveillance performance. In this review, we analyzed the main risk factors of NAFLD-related HCC, the validated screening methods and the future perspectives.
https://www.mdpi.com/1422-0067/20/22/5613/pdf
Pennisi G., Celsa C., Giammanco A., Spatola F., Petta S. (2019). The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 20(22), 5613 [10.3390/ijms20225613].
File in questo prodotto:
File Dimensione Formato  
ijms-20-05613.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 764.16 kB
Formato Adobe PDF
764.16 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/387180
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 27
social impact